Insilico Medicine
UnclaimedAccelerating drug discovery and development through generative AI and automation for longevity and sustainability.
Visit WebsiteTL;DR - Insilico Medicine
- Uses generative AI to accelerate drug discovery and development.
- Proprietary Pharma.AI platform covers biology, chemistry, and clinical stages.
- Aims to reduce time and cost in bringing new medications to market.
Pricing: Paid only
Best for: Enterprises & pros
Pricing
Paid
Insilico Medicine offers paid plans. Visit their website for current pricing details.
About Insilico Medicine
Insilico Medicine is an end-to-end generative AI-driven biotech company that transforms drug discovery and development. It leverages its proprietary Pharma.AI platform, which encompasses biology, chemistry, and clinical development, to significantly reduce the time and cost associated with bringing new medications to patients. The platform utilizes generative AI to identify novel targets, design new molecules, and advance a self-generated pipeline of drug candidates.
The company's offerings include specific AI software products like PandaOmics, Chemistry42, Generative Biologics, and Science42:DORA, which are available for licensing. These tools support various stages of drug discovery, from target identification and hit-to-lead optimization to IND-enabling studies and clinical trials. Insilico Medicine's mission is to extend healthy, productive longevity for everyone by making drug discovery more efficient and accessible.
Reviews
No reviews yet. Be the first to review Insilico Medicine!
Write a ReviewExplore More
Insilico Medicine FAQ
Insilico Medicine is an end-to-end generative AI-driven biotech company that uses its proprietary Pharma.AI platform to accelerate drug discovery and development, aiming to reduce the time and cost of bringing new medications to patients.
The website does not provide specific pricing information. Its software products are available for licensing, suggesting a paid model, likely enterprise-level or custom pricing.
No, Insilico Medicine's software products are available for licensing, indicating they are not free. There is an option to enroll for a free 'Disease Modeling and Target Discovery Course'.
Insilico Medicine is for pharmaceutical companies, biotech firms, research institutions, and scientists involved in drug discovery and development who are looking to leverage advanced generative AI and automation to enhance their processes, identify new targets, and design novel molecules more efficiently.